UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
AMENDMENT NO. 3 TO
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Q-MED, INC.
-----------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE PER SHARE
---------------------------------------
(Title of Class of Securities)
74791410
--------------
(CUSIP Number)
Bruce F. Wesson
Senior Managing Member
Claudius, L.L.C.
610 Fifth Avenue, 5th Floor
New York, NY 10020
(212) 218-4990
--------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
AUGUST 25, 1999
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
Schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934, as amended (the "Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all provisions of the Act (however,
see the Notes).
Page 1 of 14 Pages
<PAGE>
The initial Schedule 13D pertaining to the Common Stock of Q-Med, Inc., a
Delaware corporation, filed with the Securities and Exchange Commission ("SEC")
on March 30, 1998 for an event on March 18, 1998, as amended by Amendment No. 1
filed with the SEC on November 25, 1998 for an event on November 17, 1998, as
amended by Amendment No. 2 filed with the SEC on May 24, 1999 (collectively, the
"Schedule 13D"), is hereby amended to read in its entirety as follows:
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 2 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
3,094,432 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
3,094,432
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,094,432
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.6%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 3 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners International III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
280,103 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
280,103
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
280,103
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
280,103
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 4 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Employee Fund III, L.P.
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
12,669 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
12,669
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,669
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 5 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William R. Grant
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
13,334 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
13,334
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,334
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 6 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bruce F. Wesson
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
38,333 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
38,333
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
38,333
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 7 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
L. John Wilkerson
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
38,333 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
38,333
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
38,333
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 8 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Srini Conjeevaram
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
India (see Item 2)
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
9,000 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
9,000
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,000
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 74791410 PAGE 9 OF 14 PAGES
------------ --- ----
-------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
David Jahns
-------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
-------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
-------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) [ ]
-------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
-------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
9,000 (see Item 5(a))
SHARES -----------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -----------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
9,000
REPORTING -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
-------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,000
-------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
-------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
-------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
<PAGE>
ITEM 1. SECURITY AND ISSUER.
The first paragraph of Item 1 of the Schedule 13D is hereby
amended to read in its entirety as follows:
This statement covers a total of 3,495,204 fully diluted
shares of Common Stock, $.001 par value per share (the "Common Stock"), of
Q-Med, Inc., a Delaware corporation (the "Issuer"). The Reporting Persons (as
defined in Item 2 hereof) as of the date hereof hold an aggregate of (i)
1,949,523 shares of Common Stock (the "Common Shares"), (ii) $50,000 principal
amount of Convertible Notes of the Issuer (the "Notes"), which as of the date
hereof are convertible into an aggregate of 17,422 shares of Common Stock, and
(iii) warrants for the purchase of 1,528,259 shares of Common Stock (the
"Warrants"), which as of the date hereof may be exercised for an aggregate of
1,528,259 shares of Common Stock. The Common Shares, Notes and Warrants are
referred to herein, collectively, as the "Securities".
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3 of the Schedule 13D is hereby amended by adding a
paragraph to the end thereof to read as follows:
In transactions consummated on August 25, 1999, the
Partnership Reporting Persons acquired 95,238 shares of Common Stock at a
purchase price of $2.625 per share and 75,000 warrants to purchase shares of
Common Stock, for an aggregate amount of $250,000 in cash plus the exchange of
$900,000 in principal amount on certain Notes of the Issuer held by them. In
addition, 500,000 warrants to purchase shares of Common Stock were issued to the
Partnership Reporting Persons as partial consideration for the exchange by the
Partnership Reporting Persons of the aforesaid Notes held by them. Each of the
Partnership Reporting Persons paid its pro rata share of the acquisition price
of the shares of Common Stock it received.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5, subpart (a) of the Schedule 13D is hereby amended to
read in its entirety as follows:
-10-
<PAGE>
(a) Each Reporting Person owns or has the right to acquire the
number of securities shown opposite its name:
===================================================================
(1) (2) (3) (4)
Number of
Shares of
Number of Common Stock
Shares of which may be
Number of Common Stock acquired
Shares of into which pursuant to
Reporting Common Stock Owned Notes exercise of
Person Owned are Covertible Owned Warrants
-------------------------------------------------------------------
Galen 1,781,017 15,916 1,297,499
-------------------------------------------------------------------
Galen Intl 161,213 1,441 117,449
-------------------------------------------------------------------
GEF 7,293 65 5,311
-------------------------------------------------------------------
Grant 0 0 13,334
-------------------------------------------------------------------
Wesson 0 0 38,333
-------------------------------------------------------------------
Wilkerson 0 0 38,333
-------------------------------------------------------------------
Conjeevaram 0 0 9,000
-------------------------------------------------------------------
Jahns 0 0 9,000
-------------------------------------------------------------------
Total 1,949,523 17,422 1,528,259
===================================================================
===================================
(5) (6)
Percentage of
Total of Outstanding Shares of
Columns (2), Common Stock (see
(3) and (4) Note below)
-----------------------------------
3,094,432 23.6%
-----------------------------------
280,103 2.1%
-----------------------------------
12,669 0.1%
-----------------------------------
13,334 0.1%
-----------------------------------
38,333 0.1%
-----------------------------------
38,333 0.1%
-----------------------------------
9,000 0.1%
-----------------------------------
9,000 0.1%
-----------------------------------
3,495,204 26.3%
===================================
Note: The percentages shown in each row of column (6) were
calculated, for each respective row, by (i) adding the totals in the bottom row
of columns (3) and (4) to 11,582,621 (the number of shares of Common Stock
outstanding as of August 23, 1999, 1999, such number having been provided by the
Issuer to the Reporting Persons) (the "Total Adjusted Outstanding Shares"), then
(ii) dividing the amount in column (5) by the Total Adjusted Outstanding Shares,
and then (iii) expressing such quotient in terms of a percentage.
-11-
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in the statement is true, complete and
correct.
Date: August 26, 1999 GALEN PARTNERS III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
--------------------------
Senior Managing Member
GALEN PARTNERS
INTERNATIONAL III, L.P.
By: Claudius, L.L.C.
By: /s/ Bruce F. Wesson
--------------------------
Senior Managing Member
GALEN EMPLOYEE FUND III, L.P
By: Wesson Enterprises, Inc.
By: /s/ Bruce F. Wesson
--------------------------
President
[Signatures continued on next page.]
-12-
<PAGE>
WILLIAM R. GRANT
By: /s/ Bruce F. Wesson
--------------------------
Bruce F. Wesson
Attorney-in-Fact
/s/ Bruce F. Wesson
--------------------------
BRUCE F. WESSON
L. JOHN WILKERSON
By: /s/ Bruce F. Wesson
--------------------------
Bruce F. Wesson
Attorney-in-Fact
DAVID JAHNS
By: /s/ Bruce F. Wesson
--------------------------
Bruce F. Wesson
Attorney-in-Fact
SRINI CONJEEVARAM
By: /s/ Bruce F. Wesson
--------------------------
Bruce F. Wesson
Attorney-in-Fact
[Signatures continued on next page.]
-13-
<PAGE>
CLAUDIUS, L.L.C.
By: /s/ Bruce F. Wesson
--------------------------
Senior Managing Member
WESSON ENTERPRISES, INC.
By: /s/ Bruce F. Wesson
--------------------------
President
-14-
